Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.30037671 |
2 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.86250605 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.75279993 |
4 | regulation of chronic inflammatory response (GO:0002676) | 4.75175917 |
5 | response to peptidoglycan (GO:0032494) | 4.65385241 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.54264091 |
7 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.45057370 |
8 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.45057370 |
9 | leukocyte aggregation (GO:0070486) | 4.45029365 |
10 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.36275530 |
11 | positive thymic T cell selection (GO:0045059) | 4.25070690 |
12 | regulation of podosome assembly (GO:0071801) | 4.18637709 |
13 | positive regulation of heat generation (GO:0031652) | 4.15658274 |
14 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.06477113 |
15 | regulation of fever generation (GO:0031620) | 4.02105048 |
16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.97838967 |
17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.91021767 |
18 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.90516435 |
19 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.87993881 |
20 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.86268381 |
21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.84432463 |
22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.78237311 |
23 | negative thymic T cell selection (GO:0045060) | 3.69832184 |
24 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.63116280 |
25 | negative T cell selection (GO:0043383) | 3.60943407 |
26 | cellular response to nicotine (GO:0071316) | 3.56591157 |
27 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.52655707 |
28 | regulation of B cell differentiation (GO:0045577) | 3.46995908 |
29 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.44516985 |
30 | interferon-gamma production (GO:0032609) | 3.43351804 |
31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.42841064 |
32 | negative regulation of cell killing (GO:0031342) | 3.42841064 |
33 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.41484361 |
34 | activation of MAPKKK activity (GO:0000185) | 3.38083703 |
35 | NIK/NF-kappaB signaling (GO:0038061) | 3.37188678 |
36 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.36002737 |
37 | thymic T cell selection (GO:0045061) | 3.35984283 |
38 | T cell migration (GO:0072678) | 3.34651727 |
39 | positive regulation of interleukin-2 production (GO:0032743) | 3.32943443 |
40 | leukocyte cell-cell adhesion (GO:0007159) | 3.31674519 |
41 | regulation of T cell tolerance induction (GO:0002664) | 3.30692783 |
42 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.29340483 |
43 | regulation of immunoglobulin secretion (GO:0051023) | 3.28229591 |
44 | B cell receptor signaling pathway (GO:0050853) | 3.26410228 |
45 | positive T cell selection (GO:0043368) | 3.26382468 |
46 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.25621342 |
47 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.25288810 |
48 | response to interleukin-15 (GO:0070672) | 3.22307617 |
49 | response to muramyl dipeptide (GO:0032495) | 3.16188969 |
50 | germinal center formation (GO:0002467) | 3.15626342 |
51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.14062709 |
52 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.13772224 |
53 | virion attachment to host cell (GO:0019062) | 3.13540893 |
54 | adhesion of symbiont to host cell (GO:0044650) | 3.13540893 |
55 | positive regulation of interferon-alpha production (GO:0032727) | 3.13310088 |
56 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.12313388 |
57 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.10215490 |
58 | cellular response to lipopolysaccharide (GO:0071222) | 3.07879824 |
59 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.06478048 |
60 | protein localization to endosome (GO:0036010) | 3.04769247 |
61 | regulation of mononuclear cell migration (GO:0071675) | 3.04494523 |
62 | positive regulation of type 2 immune response (GO:0002830) | 3.02661546 |
63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.01127823 |
64 | T cell selection (GO:0045058) | 2.99781473 |
65 | macrophage activation involved in immune response (GO:0002281) | 2.98766023 |
66 | T-helper 1 type immune response (GO:0042088) | 2.98542878 |
67 | response to protozoan (GO:0001562) | 2.98417752 |
68 | neutrophil activation involved in immune response (GO:0002283) | 2.98071639 |
69 | negative regulation of lipid storage (GO:0010888) | 2.97348537 |
70 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.96839109 |
71 | myeloid dendritic cell differentiation (GO:0043011) | 2.96537543 |
72 | regulation of interferon-alpha production (GO:0032647) | 2.96454773 |
73 | cellular response to zinc ion (GO:0071294) | 2.95457549 |
74 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.95432470 |
75 | regulation of heat generation (GO:0031650) | 2.94949031 |
76 | decidualization (GO:0046697) | 2.94503284 |
77 | cellular response to molecule of bacterial origin (GO:0071219) | 2.94067232 |
78 | positive regulation of B cell differentiation (GO:0045579) | 2.92043822 |
79 | positive regulation of interleukin-6 production (GO:0032755) | 2.91555902 |
80 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.91264118 |
81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.91078316 |
82 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.89703183 |
83 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.88512911 |
84 | myeloid dendritic cell activation (GO:0001773) | 2.87660720 |
85 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.87569461 |
86 | immunoglobulin mediated immune response (GO:0016064) | 2.87564061 |
87 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.87071794 |
88 | defense response to protozoan (GO:0042832) | 2.86605710 |
89 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.86125324 |
90 | T cell receptor signaling pathway (GO:0050852) | 2.84326609 |
91 | cellular response to interleukin-15 (GO:0071350) | 2.84180152 |
92 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.84158092 |
93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.83899161 |
94 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.83384350 |
95 | negative regulation of interleukin-12 production (GO:0032695) | 2.83138375 |
96 | positive regulation of humoral immune response (GO:0002922) | 2.82734767 |
97 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.82078240 |
98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.81243034 |
99 | positive regulation of macrophage differentiation (GO:0045651) | 2.80708129 |
100 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.80400221 |
101 | regulation of T-helper cell differentiation (GO:0045622) | 2.79855651 |
102 | T cell costimulation (GO:0031295) | 2.79560836 |
103 | response to progesterone (GO:0032570) | 2.79181426 |
104 | * positive regulation of isotype switching (GO:0045830) | 2.78596363 |
105 | cellular response to interferon-alpha (GO:0035457) | 2.78580950 |
106 | positive regulation of acute inflammatory response (GO:0002675) | 2.78166913 |
107 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.77142973 |
108 | regulation of type 2 immune response (GO:0002828) | 2.76542605 |
109 | heterotypic cell-cell adhesion (GO:0034113) | 2.75058963 |
110 | natural killer cell differentiation (GO:0001779) | 2.75024457 |
111 | adhesion of symbiont to host (GO:0044406) | 2.75002055 |
112 | response to type I interferon (GO:0034340) | 2.73570491 |
113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.73569499 |
114 | lymphocyte costimulation (GO:0031294) | 2.73146624 |
115 | response to laminar fluid shear stress (GO:0034616) | 2.73126424 |
116 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.72836459 |
117 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.72662689 |
118 | * positive regulation of B cell mediated immunity (GO:0002714) | 2.72238772 |
119 | * positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.72238772 |
120 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.71899125 |
121 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70872927 |
122 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.70575351 |
123 | mature B cell differentiation (GO:0002335) | 2.68398443 |
124 | negative regulation of viral genome replication (GO:0045071) | 2.68321355 |
125 | regulation of tolerance induction (GO:0002643) | 2.67521504 |
126 | cell adhesion mediated by integrin (GO:0033627) | 2.67155753 |
127 | positive regulation of tolerance induction (GO:0002645) | 2.66777399 |
128 | natural killer cell activation (GO:0030101) | 2.66295410 |
129 | cellular response to virus (GO:0098586) | 2.66176185 |
130 | granulocyte activation (GO:0036230) | 2.65746127 |
131 | dendritic cell differentiation (GO:0097028) | 2.64270490 |
132 | positive regulation of interferon-beta production (GO:0032728) | 2.63773677 |
133 | cellular response to type I interferon (GO:0071357) | 2.63235022 |
134 | type I interferon signaling pathway (GO:0060337) | 2.63235022 |
135 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.62991187 |
136 | regulation of interleukin-6 production (GO:0032675) | 2.62873202 |
137 | positive regulation of interleukin-12 production (GO:0032735) | 2.62534188 |
138 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.62314414 |
139 | regulation of interleukin-12 production (GO:0032655) | 2.61354624 |
140 | wound healing, spreading of epidermal cells (GO:0035313) | 2.60321529 |
141 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.60108307 |
142 | mature B cell differentiation involved in immune response (GO:0002313) | 2.59871232 |
143 | chronic inflammatory response (GO:0002544) | 2.59448127 |
144 | interferon-gamma secretion (GO:0072643) | 2.59398035 |
145 | regulation of regulatory T cell differentiation (GO:0045589) | 2.58245058 |
146 | positive regulation of chemokine production (GO:0032722) | 2.57175574 |
147 | regulation of necroptotic process (GO:0060544) | 2.56868329 |
148 | monocyte chemotaxis (GO:0002548) | 2.56508879 |
149 | neutrophil activation (GO:0042119) | 2.56447037 |
150 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56255950 |
151 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.56052577 |
152 | cellular response to biotic stimulus (GO:0071216) | 2.56004324 |
153 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.55841454 |
154 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55098111 |
155 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.54942389 |
156 | positive regulation of natural killer cell activation (GO:0032816) | 2.54516828 |
157 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.53669293 |
158 | regulation of response to interferon-gamma (GO:0060330) | 2.53354667 |
159 | positive regulation by symbiont of host defense response (GO:0052509) | 2.53167647 |
160 | modulation by symbiont of host defense response (GO:0052031) | 2.53167647 |
161 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.53167647 |
162 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.53167647 |
163 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.53167647 |
164 | modulation by symbiont of host immune response (GO:0052553) | 2.53167647 |
165 | skin morphogenesis (GO:0043589) | 2.53077811 |
166 | membrane raft organization (GO:0031579) | 2.51373026 |
167 | regulation of vitamin metabolic process (GO:0030656) | 2.50930963 |
168 | substrate-dependent cell migration (GO:0006929) | 2.50190272 |
169 | oligosaccharide catabolic process (GO:0009313) | 2.49683067 |
170 | response to manganese ion (GO:0010042) | 2.49560593 |
171 | glycosphingolipid catabolic process (GO:0046479) | 2.49402562 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.58430878 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.80775920 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.51274669 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.86247963 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60526137 |
6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.40475586 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.28297501 |
8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.04586526 |
9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.00191541 |
10 | MYC_22102868_ChIP-Seq_BL_Human | 2.98441928 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.96424544 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.77028027 |
13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75735716 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74554020 |
15 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.71100196 |
16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.70422936 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.68635438 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62066209 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57850512 |
20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.55111399 |
21 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.51808286 |
22 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45123107 |
23 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.44309172 |
24 | MYB_26560356_Chip-Seq_TH2_Human | 2.44066226 |
25 | * MAF_26560356_Chip-Seq_TH1_Human | 2.34696241 |
26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.25476534 |
27 | MYB_26560356_Chip-Seq_TH1_Human | 2.16805239 |
28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.09220266 |
29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.02170241 |
30 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00342427 |
31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.00108823 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98810639 |
33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.95924658 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.94015096 |
35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92209061 |
36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.91749177 |
37 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.89930211 |
38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88054501 |
39 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.83976623 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80791269 |
41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77631132 |
42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.71349720 |
43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70420086 |
44 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.70173057 |
45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.69863621 |
46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67819774 |
47 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67350208 |
48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62086302 |
49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60236719 |
50 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.59684628 |
51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.56850329 |
52 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56653241 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56295801 |
54 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.55092564 |
55 | * ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.52389913 |
56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.47050190 |
57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45334910 |
58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43944540 |
59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.42447792 |
60 | MAF_26560356_Chip-Seq_TH2_Human | 1.40439451 |
61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37412848 |
62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35391187 |
63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32856336 |
64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31641009 |
65 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29859714 |
66 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29859714 |
67 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.28596665 |
68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26546663 |
69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25983491 |
70 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24139150 |
71 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23435908 |
72 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.22395696 |
73 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17344418 |
74 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16932545 |
75 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16018935 |
76 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14827407 |
77 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14562152 |
78 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12591838 |
79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11988594 |
80 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11758367 |
81 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.11694454 |
82 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11543959 |
83 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11385770 |
84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.08593176 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08080061 |
86 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.07930230 |
87 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06440592 |
88 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.05969640 |
89 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.05249794 |
90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05186671 |
91 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.04856540 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03229139 |
93 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.02018899 |
94 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.01379924 |
95 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01036762 |
96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.00494466 |
97 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00372602 |
98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00372568 |
99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99586167 |
100 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.98649780 |
101 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98520876 |
102 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98279228 |
103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.97497240 |
104 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97211689 |
105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95862398 |
106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.95634151 |
107 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.94785220 |
108 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.94013261 |
109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93997032 |
110 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92591702 |
111 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91666057 |
112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.91603070 |
113 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.91456426 |
114 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91082279 |
115 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.90696406 |
116 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88639049 |
117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88027731 |
118 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86519750 |
119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.85493512 |
120 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.85448219 |
121 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85034522 |
122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84524153 |
123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82297491 |
124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81995590 |
125 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81579488 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.66257368 |
2 | MP0003436_decreased_susceptibility_to | 3.04449902 |
3 | MP0005671_abnormal_response_to | 2.92960404 |
4 | MP0000685_abnormal_immune_system | 2.92440737 |
5 | MP0003303_peritoneal_inflammation | 2.86669277 |
6 | MP0005387_immune_system_phenotype | 2.82384915 |
7 | MP0001790_abnormal_immune_system | 2.82384915 |
8 | MP0009785_altered_susceptibility_to | 2.81487575 |
9 | MP0005058_abnormal_lysosome_morphology | 2.76448319 |
10 | MP0005000_abnormal_immune_tolerance | 2.73054999 |
11 | MP0001800_abnormal_humoral_immune | 2.72440847 |
12 | MP0003763_abnormal_thymus_physiology | 2.56401995 |
13 | MP0002452_abnormal_antigen_presenting | 2.54987937 |
14 | MP0003300_gastrointestinal_ulcer | 2.52314419 |
15 | MP0005451_abnormal_body_composition | 2.44715969 |
16 | MP0002723_abnormal_immune_serum | 2.38460050 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.31535766 |
18 | MP0009840_abnormal_foam_cell | 2.31461964 |
19 | MP0005025_abnormal_response_to | 2.28930996 |
20 | MP0002420_abnormal_adaptive_immunity | 2.27369036 |
21 | MP0001819_abnormal_immune_cell | 2.25861655 |
22 | MP0002419_abnormal_innate_immunity | 2.17392727 |
23 | MP0010352_gastrointestinal_tract_polyps | 2.16653813 |
24 | MP0006082_CNS_inflammation | 2.13485380 |
25 | MP0002006_tumorigenesis | 2.10358453 |
26 | MP0002405_respiratory_system_inflammati | 2.06855111 |
27 | MP0009333_abnormal_splenocyte_physiolog | 2.01380805 |
28 | MP0002398_abnormal_bone_marrow | 2.01187041 |
29 | MP0004947_skin_inflammation | 2.00937310 |
30 | MP0002332_abnormal_exercise_endurance | 1.99674250 |
31 | MP0002166_altered_tumor_susceptibility | 1.98500845 |
32 | MP0008004_abnormal_stomach_pH | 1.94443273 |
33 | MP0003075_altered_response_to | 1.94026431 |
34 | MP0003724_increased_susceptibility_to | 1.93003788 |
35 | MP0003279_aneurysm | 1.92290892 |
36 | MP0004808_abnormal_hematopoietic_stem | 1.90496782 |
37 | MP0003705_abnormal_hypodermis_morpholog | 1.88242429 |
38 | MP0000716_abnormal_immune_system | 1.87074479 |
39 | MP0001853_heart_inflammation | 1.82360675 |
40 | MP0010155_abnormal_intestine_physiology | 1.79029991 |
41 | MP0002933_joint_inflammation | 1.78825399 |
42 | MP0005464_abnormal_platelet_physiology | 1.77906455 |
43 | MP0008438_abnormal_cutaneous_collagen | 1.76436741 |
44 | MP0000858_altered_metastatic_potential | 1.76065585 |
45 | MP0003950_abnormal_plasma_membrane | 1.75498321 |
46 | MP0001542_abnormal_bone_strength | 1.67229086 |
47 | MP0000689_abnormal_spleen_morphology | 1.65677696 |
48 | MP0002396_abnormal_hematopoietic_system | 1.65290090 |
49 | MP0001533_abnormal_skeleton_physiology | 1.63135278 |
50 | MP0005023_abnormal_wound_healing | 1.61802407 |
51 | MP0003566_abnormal_cell_adhesion | 1.60441552 |
52 | MP0002722_abnormal_immune_system | 1.60388881 |
53 | MP0003091_abnormal_cell_migration | 1.60279986 |
54 | MP0009278_abnormal_bone_marrow | 1.59062694 |
55 | MP0002139_abnormal_hepatobiliary_system | 1.57657457 |
56 | MP0001845_abnormal_inflammatory_respons | 1.55707850 |
57 | MP0003448_altered_tumor_morphology | 1.52844497 |
58 | MP0004510_myositis | 1.52159803 |
59 | MP0001873_stomach_inflammation | 1.51893117 |
60 | MP0002429_abnormal_blood_cell | 1.51811459 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.50526915 |
62 | MP0001545_abnormal_hematopoietic_system | 1.50526915 |
63 | MP0005257_abnormal_intraocular_pressure | 1.41814727 |
64 | MP0000703_abnormal_thymus_morphology | 1.40761336 |
65 | MP0002254_reproductive_system_inflammat | 1.31947040 |
66 | MP0003172_abnormal_lysosome_physiology | 1.28111794 |
67 | MP0003045_fibrosis | 1.27499479 |
68 | MP0002998_abnormal_bone_remodeling | 1.25664433 |
69 | MP0005165_increased_susceptibility_to | 1.24742110 |
70 | MP0001958_emphysema | 1.24258429 |
71 | MP0002138_abnormal_hepatobiliary_system | 1.23558207 |
72 | MP0003866_abnormal_defecation | 1.19807524 |
73 | MP0003453_abnormal_keratinocyte_physiol | 1.17558487 |
74 | MP0000604_amyloidosis | 1.15942234 |
75 | MP0000733_abnormal_muscle_development | 1.15506761 |
76 | MP0000465_gastrointestinal_hemorrhage | 1.15181280 |
77 | MP0005275_abnormal_skin_tensile | 1.11260121 |
78 | MP0000490_abnormal_crypts_of | 1.08584030 |
79 | MP0003806_abnormal_nucleotide_metabolis | 1.07433268 |
80 | MP0008469_abnormal_protein_level | 1.06861684 |
81 | MP0005076_abnormal_cell_differentiation | 1.06268264 |
82 | MP0002877_abnormal_melanocyte_morpholog | 1.05573935 |
83 | MP0005390_skeleton_phenotype | 1.05476315 |
84 | MP0006054_spinal_hemorrhage | 1.04859969 |
85 | MP0009764_decreased_sensitivity_to | 1.03687471 |
86 | MP0000767_abnormal_smooth_muscle | 1.02444356 |
87 | MP0003656_abnormal_erythrocyte_physiolo | 0.98278381 |
88 | MP0002928_abnormal_bile_duct | 0.96217838 |
89 | MP0008260_abnormal_autophagy | 0.92514958 |
90 | MP0005167_abnormal_blood-brain_barrier | 0.90517292 |
91 | MP0001243_abnormal_dermal_layer | 0.85928752 |
92 | MP0002060_abnormal_skin_morphology | 0.85515078 |
93 | MP0003795_abnormal_bone_structure | 0.83365768 |
94 | MP0002019_abnormal_tumor_incidence | 0.81697393 |
95 | MP0004272_abnormal_basement_membrane | 0.81591304 |
96 | MP0001851_eye_inflammation | 0.81531863 |
97 | MP0009765_abnormal_xenobiotic_induced | 0.81530875 |
98 | MP0004883_abnormal_blood_vessel | 0.81269082 |
99 | MP0000343_altered_response_to | 0.80643395 |
100 | MP0000249_abnormal_blood_vessel | 0.79928154 |
101 | MP0001849_ear_inflammation | 0.79907404 |
102 | MP0003828_pulmonary_edema | 0.78255231 |
103 | MP0005595_abnormal_vascular_smooth | 0.76951661 |
104 | MP0010307_abnormal_tumor_latency | 0.74177944 |
105 | MP0009384_cardiac_valve_regurgitation | 0.73862193 |
106 | MP0004858_abnormal_nervous_system | 0.72862162 |
107 | MP0001663_abnormal_digestive_system | 0.70547857 |
108 | MP0002168_other_aberrant_phenotype | 0.70327780 |
109 | MP0002136_abnormal_kidney_physiology | 0.69600493 |
110 | MP0003191_abnormal_cellular_cholesterol | 0.68485880 |
111 | MP0005166_decreased_susceptibility_to | 0.67813665 |
112 | MP0003252_abnormal_bile_duct | 0.67378046 |
113 | MP0001879_abnormal_lymphatic_vessel | 0.67260989 |
114 | MP0005503_abnormal_tendon_morphology | 0.66868791 |
115 | MP0005375_adipose_tissue_phenotype | 0.66818870 |
116 | MP0010234_abnormal_vibrissa_follicle | 0.66606392 |
117 | MP0001348_abnormal_lacrimal_gland | 0.66190690 |
118 | MP0005623_abnormal_meninges_morphology | 0.65979056 |
119 | MP0005666_abnormal_adipose_tissue | 0.65063086 |
120 | MP0009763_increased_sensitivity_to | 0.64687203 |
121 | MP0001216_abnormal_epidermal_layer | 0.64118439 |
122 | MP0005310_abnormal_salivary_gland | 0.60039716 |
123 | MP0001191_abnormal_skin_condition | 0.58761502 |
124 | MP0010368_abnormal_lymphatic_system | 0.58503723 |
125 | MP0005164_abnormal_response_to | 0.58364328 |
126 | MP0009931_abnormal_skin_appearance | 0.55866833 |
127 | MP0001614_abnormal_blood_vessel | 0.54900138 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.82647750 |
2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.82647750 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.82647750 |
4 | Eczematoid dermatitis (HP:0000976) | 4.29058907 |
5 | Dysostosis multiplex (HP:0000943) | 4.06322375 |
6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.92502424 |
7 | Nuclear cataract (HP:0100018) | 3.71804655 |
8 | Recurrent abscess formation (HP:0002722) | 3.62455679 |
9 | Loss of speech (HP:0002371) | 3.50131869 |
10 | Vacuolated lymphocytes (HP:0001922) | 3.44549818 |
11 | Myositis (HP:0100614) | 3.40856695 |
12 | Autoimmune thrombocytopenia (HP:0001973) | 3.34440171 |
13 | Aortic aneurysm (HP:0004942) | 3.31526578 |
14 | Cellulitis (HP:0100658) | 3.27031699 |
15 | Stomatitis (HP:0010280) | 3.23803712 |
16 | Recurrent fungal infections (HP:0002841) | 3.23388981 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.21502615 |
18 | Pustule (HP:0200039) | 3.20611958 |
19 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.18614992 |
20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.18614992 |
21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.18614992 |
22 | Recurrent viral infections (HP:0004429) | 3.17012115 |
23 | Recurrent bronchitis (HP:0002837) | 3.14423161 |
24 | Mediastinal lymphadenopathy (HP:0100721) | 3.12226763 |
25 | Protrusio acetabuli (HP:0003179) | 3.05697359 |
26 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03537791 |
27 | Mucopolysacchariduria (HP:0008155) | 3.03537791 |
28 | T lymphocytopenia (HP:0005403) | 3.01600921 |
29 | Syringomyelia (HP:0003396) | 3.00478382 |
30 | Spinal cord lesions (HP:0100561) | 3.00478382 |
31 | Systemic lupus erythematosus (HP:0002725) | 2.97865300 |
32 | Abnormality of T cell number (HP:0011839) | 2.97392263 |
33 | Agammaglobulinemia (HP:0004432) | 2.95624146 |
34 | Increased density of long bones (HP:0006392) | 2.92765483 |
35 | Chronic otitis media (HP:0000389) | 2.89707792 |
36 | Interstitial pulmonary disease (HP:0006530) | 2.87804960 |
37 | Vasculitis (HP:0002633) | 2.86786826 |
38 | Emphysema (HP:0002097) | 2.85402429 |
39 | Increased cerebral lipofuscin (HP:0011813) | 2.76296619 |
40 | Dilatation of the ascending aorta (HP:0005111) | 2.75707535 |
41 | Keratoconjunctivitis sicca (HP:0001097) | 2.73029382 |
42 | Axonal loss (HP:0003447) | 2.73023397 |
43 | Nasal polyposis (HP:0100582) | 2.72272268 |
44 | Osteolytic defects of the hand bones (HP:0009699) | 2.71685041 |
45 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.71685041 |
46 | Gastrointestinal stroma tumor (HP:0100723) | 2.68723640 |
47 | Thrombocytosis (HP:0001894) | 2.64788345 |
48 | Cerebral aneurysm (HP:0004944) | 2.63570543 |
49 | Lymphopenia (HP:0001888) | 2.60555246 |
50 | Neurofibrillary tangles (HP:0002185) | 2.59720146 |
51 | Vertebral compression fractures (HP:0002953) | 2.59036954 |
52 | Disinhibition (HP:0000734) | 2.55145901 |
53 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.53219289 |
54 | Panhypogammaglobulinemia (HP:0003139) | 2.52098957 |
55 | Abnormality of T cells (HP:0002843) | 2.51530091 |
56 | Orchitis (HP:0100796) | 2.51083068 |
57 | Meningitis (HP:0001287) | 2.49514192 |
58 | IgM deficiency (HP:0002850) | 2.48140544 |
59 | Abnormality of the nasal mucosa (HP:0000433) | 2.45584718 |
60 | Recurrent skin infections (HP:0001581) | 2.45561222 |
61 | Aortic dissection (HP:0002647) | 2.45062120 |
62 | Peritonitis (HP:0002586) | 2.44744024 |
63 | Inflammation of the large intestine (HP:0002037) | 2.44016888 |
64 | Recurrent cutaneous fungal infections (HP:0011370) | 2.43229309 |
65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.43229309 |
66 | Parakeratosis (HP:0001036) | 2.40445620 |
67 | Premature rupture of membranes (HP:0001788) | 2.40182531 |
68 | Amyloidosis (HP:0011034) | 2.38632616 |
69 | Abnormality of the fingertips (HP:0001211) | 2.38345952 |
70 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.37563148 |
71 | Keratoconjunctivitis (HP:0001096) | 2.37160922 |
72 | Increased serum ferritin (HP:0003281) | 2.37008075 |
73 | Vascular tortuosity (HP:0004948) | 2.36303751 |
74 | Gastrointestinal inflammation (HP:0004386) | 2.35432626 |
75 | Osteomyelitis (HP:0002754) | 2.33928405 |
76 | Abnormal platelet volume (HP:0011876) | 2.31041030 |
77 | Asymmetric septal hypertrophy (HP:0001670) | 2.30732039 |
78 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29942235 |
79 | Myocardial infarction (HP:0001658) | 2.29505677 |
80 | Absent frontal sinuses (HP:0002688) | 2.27977825 |
81 | Arterial thrombosis (HP:0004420) | 2.26767366 |
82 | Optic neuritis (HP:0100653) | 2.24190088 |
83 | Retrobulbar optic neuritis (HP:0100654) | 2.24190088 |
84 | Pulmonary infiltrates (HP:0002113) | 2.24114469 |
85 | Abnormality of macrophages (HP:0004311) | 2.23887383 |
86 | Colitis (HP:0002583) | 2.19827989 |
87 | Atrophic scars (HP:0001075) | 2.18606530 |
88 | IgA deficiency (HP:0002720) | 2.18523805 |
89 | Spontaneous hematomas (HP:0007420) | 2.17669147 |
90 | Prolonged neonatal jaundice (HP:0006579) | 2.17573854 |
91 | Arterial tortuosity (HP:0005116) | 2.16702593 |
92 | Cerebral inclusion bodies (HP:0100314) | 2.16111940 |
93 | Broad face (HP:0000283) | 2.15416879 |
94 | Papilloma (HP:0012740) | 2.14363238 |
95 | Verrucae (HP:0200043) | 2.14363238 |
96 | Abnormality of the pericardium (HP:0001697) | 2.12652684 |
97 | Apathy (HP:0000741) | 2.12029925 |
98 | Joint stiffness (HP:0001387) | 2.11156889 |
99 | Persistence of primary teeth (HP:0006335) | 2.10469734 |
100 | Increased IgE level (HP:0003212) | 2.09995744 |
101 | Increased mean platelet volume (HP:0011877) | 2.06628393 |
102 | Hepatosplenomegaly (HP:0001433) | 2.06556053 |
103 | Progressive neurologic deterioration (HP:0002344) | 2.06361316 |
104 | Hematochezia (HP:0002573) | 2.06106589 |
105 | Periodontitis (HP:0000704) | 2.04732022 |
106 | Gangrene (HP:0100758) | 2.04659348 |
107 | Leukocytosis (HP:0001974) | 2.04154338 |
108 | Obstructive lung disease (HP:0006536) | 2.03773318 |
109 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03773318 |
110 | Achilles tendon contracture (HP:0001771) | 2.03564950 |
111 | Distal lower limb muscle weakness (HP:0009053) | 2.02386708 |
112 | Skin ulcer (HP:0200042) | 2.01793261 |
113 | Spondylolisthesis (HP:0003302) | 2.01654265 |
114 | Abnormality of T cell physiology (HP:0011840) | 2.01440447 |
115 | Gastrointestinal infarctions (HP:0005244) | 2.00830028 |
116 | Diminished motivation (HP:0000745) | 2.00426737 |
117 | Restrictive lung disease (HP:0002091) | 1.99890937 |
118 | Gingivitis (HP:0000230) | 1.99633422 |
119 | Short nail (HP:0001799) | 1.97969356 |
120 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97629572 |
121 | Upper limb amyotrophy (HP:0009129) | 1.97558151 |
122 | Distal upper limb amyotrophy (HP:0007149) | 1.97558151 |
123 | Cervical subluxation (HP:0003308) | 1.96952345 |
124 | Thin bony cortex (HP:0002753) | 1.96936995 |
125 | Ulnar bowing (HP:0003031) | 1.96757725 |
126 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.95570830 |
127 | Hypergammaglobulinemia (HP:0010702) | 1.94859449 |
128 | Chronic diarrhea (HP:0002028) | 1.93689427 |
129 | IgG deficiency (HP:0004315) | 1.92555851 |
130 | Epistaxis (HP:0000421) | 1.91273036 |
131 | Increased IgM level (HP:0003496) | 1.90015865 |
132 | Mutism (HP:0002300) | 1.89361327 |
133 | J-shaped sella turcica (HP:0002680) | 1.88695086 |
134 | Mitral valve prolapse (HP:0001634) | 1.88010236 |
135 | Radial bowing (HP:0002986) | 1.87960366 |
136 | Prolonged bleeding time (HP:0003010) | 1.86595374 |
137 | Basal ganglia calcification (HP:0002135) | 1.86534198 |
138 | Distal lower limb amyotrophy (HP:0008944) | 1.85402237 |
139 | Shallow orbits (HP:0000586) | 1.83694191 |
140 | Combined immunodeficiency (HP:0005387) | 1.82774039 |
141 | Bone pain (HP:0002653) | 1.82764376 |
142 | Chest pain (HP:0100749) | 1.82479428 |
143 | Eosinophilia (HP:0001880) | 1.82165403 |
144 | Glomerulopathy (HP:0100820) | 1.80544939 |
145 | Abnormality of the Achilles tendon (HP:0005109) | 1.80244028 |
146 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.79353575 |
147 | Hypertensive crisis (HP:0100735) | 1.78827323 |
148 | Hyperparathyroidism (HP:0000843) | 1.78017488 |
149 | Aseptic necrosis (HP:0010885) | 1.76877191 |
150 | Purpura (HP:0000979) | 1.76502561 |
151 | Autoimmune hemolytic anemia (HP:0001890) | 1.74060757 |
152 | Fused cervical vertebrae (HP:0002949) | 1.74009316 |
153 | Blue sclerae (HP:0000592) | 1.72866663 |
154 | Hemoptysis (HP:0002105) | 1.72430197 |
155 | Acne (HP:0001061) | 1.70619729 |
156 | Neuronal loss in central nervous system (HP:0002529) | 1.69843987 |
157 | Anorexia (HP:0002039) | 1.68670406 |
158 | Ovoid vertebral bodies (HP:0003300) | 1.67310343 |
159 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.66218484 |
160 | Protuberant abdomen (HP:0001538) | 1.66066448 |
161 | Polyneuropathy (HP:0001271) | 1.64978700 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.55676776 |
2 | TAOK2 | 3.21978227 |
3 | MAP3K14 | 3.12984955 |
4 | JAK3 | 2.81145407 |
5 | TXK | 2.76921757 |
6 | TBK1 | 2.55028983 |
7 | STK10 | 2.54369319 |
8 | MAP3K10 | 2.49226881 |
9 | TTN | 2.35736969 |
10 | PRPF4B | 2.33940634 |
11 | ERN1 | 2.33129832 |
12 | GRK7 | 2.32102098 |
13 | ZAP70 | 2.15549764 |
14 | TYK2 | 1.99594138 |
15 | IKBKE | 1.92800668 |
16 | RPS6KA4 | 1.91781800 |
17 | TGFBR2 | 1.91169572 |
18 | LRRK2 | 1.90048798 |
19 | FGFR4 | 1.87585742 |
20 | IKBKB | 1.85261298 |
21 | ITK | 1.77426225 |
22 | JAK1 | 1.76444749 |
23 | LATS2 | 1.66192000 |
24 | TRIB3 | 1.63781203 |
25 | BTK | 1.61591907 |
26 | EEF2K | 1.58575881 |
27 | BLK | 1.58096326 |
28 | CHUK | 1.56683671 |
29 | NME2 | 1.54325889 |
30 | IRAK4 | 1.45653033 |
31 | PIM2 | 1.44166877 |
32 | HCK | 1.42578219 |
33 | CSK | 1.42275218 |
34 | KIT | 1.41733305 |
35 | RIPK4 | 1.40336198 |
36 | MAP3K13 | 1.38757858 |
37 | EPHB1 | 1.37143932 |
38 | CDC42BPA | 1.33915134 |
39 | PIM1 | 1.32965443 |
40 | MATK | 1.30671417 |
41 | TEC | 1.30328639 |
42 | LCK | 1.28791682 |
43 | GRK6 | 1.27599046 |
44 | MARK3 | 1.26111231 |
45 | FGFR3 | 1.25611524 |
46 | CSF1R | 1.25402481 |
47 | BMPR2 | 1.25065117 |
48 | PKN2 | 1.24743343 |
49 | SYK | 1.24099470 |
50 | MST4 | 1.22544121 |
51 | MAP2K3 | 1.17595234 |
52 | NLK | 1.16988885 |
53 | ABL2 | 1.16336191 |
54 | BMX | 1.12124446 |
55 | IRAK3 | 1.10549078 |
56 | TRPM7 | 1.09861426 |
57 | IRAK2 | 1.04603900 |
58 | EPHA3 | 1.03774684 |
59 | ARAF | 0.96132547 |
60 | SIK2 | 0.95642734 |
61 | FGR | 0.95560077 |
62 | CDK12 | 0.94357943 |
63 | TESK2 | 0.92589237 |
64 | MAP3K1 | 0.91970534 |
65 | EPHA2 | 0.90845874 |
66 | PTK6 | 0.88892712 |
67 | NEK9 | 0.88094595 |
68 | LYN | 0.86383505 |
69 | RIPK1 | 0.86091830 |
70 | PRKCH | 0.84917648 |
71 | SIK1 | 0.83974283 |
72 | LIMK1 | 0.83467741 |
73 | ICK | 0.83289567 |
74 | MAP3K3 | 0.78100974 |
75 | SIK3 | 0.78015335 |
76 | MOS | 0.77446236 |
77 | BRD4 | 0.77443251 |
78 | TAOK1 | 0.75191456 |
79 | LMTK2 | 0.73702286 |
80 | PDGFRB | 0.69020284 |
81 | PAK4 | 0.67916724 |
82 | PRKD2 | 0.67859021 |
83 | PAK2 | 0.66060054 |
84 | FLT3 | 0.65945849 |
85 | SMG1 | 0.65916258 |
86 | JAK2 | 0.65658361 |
87 | CDK6 | 0.65585176 |
88 | HIPK2 | 0.65569464 |
89 | MAP3K5 | 0.64761242 |
90 | TGFBR1 | 0.63753012 |
91 | CLK1 | 0.62423672 |
92 | DDR2 | 0.60606338 |
93 | PRKCQ | 0.58993348 |
94 | ABL1 | 0.58849431 |
95 | MET | 0.58087376 |
96 | KDR | 0.57233656 |
97 | MAP3K11 | 0.57061806 |
98 | INSR | 0.55350621 |
99 | MAP3K8 | 0.54687024 |
100 | MYLK | 0.53599571 |
101 | BRAF | 0.53363646 |
102 | RPS6KB2 | 0.51116956 |
103 | MAP3K7 | 0.50872502 |
104 | MAPKAPK2 | 0.47656779 |
105 | DYRK3 | 0.47389578 |
106 | MELK | 0.45322443 |
107 | ERBB4 | 0.44308914 |
108 | PDGFRA | 0.43873974 |
109 | PTK2 | 0.43766665 |
110 | CDK4 | 0.42702418 |
111 | RPS6KA6 | 0.40944688 |
112 | TESK1 | 0.39667135 |
113 | PAK1 | 0.38802013 |
114 | STK38 | 0.38425888 |
115 | MTOR | 0.37896601 |
116 | STK4 | 0.37091583 |
117 | DAPK3 | 0.35049956 |
118 | EPHB2 | 0.35001810 |
119 | GSK3A | 0.34969648 |
120 | DYRK1B | 0.34736587 |
121 | IRAK1 | 0.34663130 |
122 | EGFR | 0.34125787 |
123 | RPS6KA2 | 0.33852360 |
124 | ADRBK2 | 0.32851621 |
125 | TNK2 | 0.32849377 |
126 | PRKG2 | 0.31978545 |
127 | STK3 | 0.31118676 |
128 | RPS6KL1 | 0.30910152 |
129 | RPS6KC1 | 0.30910152 |
130 | IGF1R | 0.29944959 |
131 | CDK9 | 0.29357365 |
132 | DMPK | 0.29115569 |
133 | MST1R | 0.28313677 |
134 | PDPK1 | 0.27895449 |
135 | MAPK7 | 0.26149009 |
136 | MAPK4 | 0.23807594 |
137 | MAP2K6 | 0.22684661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.94939365 |
2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.87669612 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82861764 |
4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.72912201 |
5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.30502565 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.24487944 |
7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23977520 |
8 | Measles_Homo sapiens_hsa05162 | 2.23715257 |
9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15695952 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 2.13604744 |
11 | Malaria_Homo sapiens_hsa05144 | 1.99795210 |
12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.95253431 |
13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92272615 |
14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91777429 |
15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.90309469 |
16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83601272 |
17 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.81117959 |
18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77579978 |
19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71527519 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.70155743 |
21 | Legionellosis_Homo sapiens_hsa05134 | 1.69699235 |
22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.63567858 |
23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61441858 |
24 | Shigellosis_Homo sapiens_hsa05131 | 1.61293384 |
25 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.60845448 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59147603 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53390802 |
28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49464245 |
29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47651661 |
30 | Tuberculosis_Homo sapiens_hsa05152 | 1.45157616 |
31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45028573 |
32 | Pertussis_Homo sapiens_hsa05133 | 1.44152528 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.43336764 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.38907259 |
35 | Salmonella infection_Homo sapiens_hsa05132 | 1.38791162 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.38668438 |
37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.37113733 |
38 | Prion diseases_Homo sapiens_hsa05020 | 1.36545880 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.32391703 |
40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32162718 |
41 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.31318047 |
42 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.25287965 |
43 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.24039221 |
44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23551594 |
45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20536750 |
46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15025112 |
47 | Platelet activation_Homo sapiens_hsa04611 | 1.13596642 |
48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13198426 |
49 | Asthma_Homo sapiens_hsa05310 | 1.11405077 |
50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10796823 |
51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07130746 |
52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.05979203 |
53 | HTLV-I infection_Homo sapiens_hsa05166 | 1.01039786 |
54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99773183 |
55 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.99272470 |
56 | Amoebiasis_Homo sapiens_hsa05146 | 0.98302917 |
57 | Focal adhesion_Homo sapiens_hsa04510 | 0.95284857 |
58 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93183981 |
59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.92285252 |
60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91491720 |
61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.89073860 |
62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89053438 |
63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.88665670 |
64 | Adherens junction_Homo sapiens_hsa04520 | 0.87685630 |
65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85344535 |
66 | Hepatitis C_Homo sapiens_hsa05160 | 0.85080380 |
67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.83981842 |
68 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.83677873 |
69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82924733 |
70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81624975 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79580502 |
72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.76991843 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.76314577 |
74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.68157879 |
75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67241308 |
76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67045569 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62602075 |
78 | Colorectal cancer_Homo sapiens_hsa05210 | 0.62249833 |
79 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61893013 |
80 | Prostate cancer_Homo sapiens_hsa05215 | 0.60488373 |
81 | Phagosome_Homo sapiens_hsa04145 | 0.60356840 |
82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.59372698 |
83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58181704 |
84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56214272 |
85 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54486391 |
86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54172865 |
87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52924525 |
88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52803651 |
89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51200194 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51186513 |
91 | Lysosome_Homo sapiens_hsa04142 | 0.51184738 |
92 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49628937 |
93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49356880 |
94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49310151 |
95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.48840933 |
96 | Pathways in cancer_Homo sapiens_hsa05200 | 0.48394928 |
97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47985007 |
98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46421464 |
99 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45571630 |
100 | Bladder cancer_Homo sapiens_hsa05219 | 0.44488370 |
101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39900047 |
102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39693021 |
103 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39494806 |
104 | Insulin resistance_Homo sapiens_hsa04931 | 0.39035592 |
105 | Endocytosis_Homo sapiens_hsa04144 | 0.38877500 |
106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38216891 |
107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37753766 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36128109 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36090486 |
110 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35896210 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34418705 |
112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30763335 |
113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30166293 |
114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28942749 |
115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28106535 |
116 | Ribosome_Homo sapiens_hsa03010 | 0.26286094 |
117 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.25612299 |